Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease. ACP journal club [ACP J Club] Journal article

Title	Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease.
Author(s)	Marshall JK
Institution	McMaster University, Hamilton, Ontario, Canada.
Source	ACP J Club 2008 May/June; 148(4):9.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	18588260

Advertise on this site.